Cyclic nucleotide phosphodiesterases: Diversity, classification, structure function;Fosfodiesterasas de nucleotidos ciclicos: Diversidad, Clasificacion, estructura y funcion

Acta Cientifica Venezolana

Volumn 48, Issue 3, 1997, Pages 145-153

  Rascón, Ana ^a  

^a FACULTAD DE CIENCIAS   (Venezuela)

Author keywords

cAMP; cGMP; Phosphodiesterases; Trypanosomatides

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; CYCLIC AMP; CYCLIC GMP; ISOENZYME;

ANIMAL; CELL DIFFERENTIATION; CHEMISTRY; CLASSIFICATION; CYTOLOGY; DRUG POTENTIATION; ENZYMOLOGY; FLAGELLATE; NOMENCLATURE; PHYSIOLOGY; REVIEW;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ANIMALS; CELL DIFFERENTIATION; CYCLIC AMP; CYCLIC GMP; ISOENZYMES; TERMINOLOGY; TRYPANOSOMATINA;

EID: 0031300632     PISSN: 00015504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (92)

1. Al-Chalabi, K.A.K., Ziz, L.A. and Al-Khayat, B. Presence and properties of cAMP phosphodiesterase from promastigote forms of Leishmania tropica and Leishmania donovani. Comp. Biochem. Physiol. 93B: 789-792, 1989.
2. Anant, J., Ong, O., Xie, H., Clarke, S., O'Brien, P. and Fung, B. In vivo differential prenylation of retinal cyclic GMP phosphodiesterase catalytic subunits. J. Biol. Chem. 267: 687-690, 1992.
3. Appleman, M.M. and Terasaki, W.L. Regulation of cyclic nucleotide phosphodiesterases. Adv. Cycl. Nucl. Res. 5: 153-163, 1975.
4. Barber, R. and Butcher, R.W. The turnover of cyclic AMP in cultured fibroblast. J. Cyclic Nucleotide Res. 6: 3-7, 1980.
5. Barber, R. and Butcher, R.W. The quantitative relationship between intracellular concentration and egrees of cyclic AMP from cultured cells. Mol. Pharmacol. 19: 38-43, 1981.
6. Beavo, J.A. Multiple isozymes of cyclic nucleotide phosphodiesterase. Adv. Sec. Mess. Phos. Res. 22: 1-38, 1988.
7. Beavo, J.A., Conti, M. and Heaslip, R.J. Cyclic nucleotide phosphodiesterases. Mol. Pharmacol. 46: 399-405, 1994.
8. Beavo, U.A., Hansen, R.S., Harrison, S.A., Hurwitz, R.L., Martins, T.J. and Mumby, M.C. Identification and properties of cyclic nucleotide phosphodiesterases. Mol. Cell. Endocrinol. 28: 387-410, 1982.
9. Beavo, J.A. and Reifsnyder, D.H. Primary sequence of cyclic nuclotide phosphodiesrerase isoenzymes and desing of selective inhibitors. Trends Pharm. Sci. 11: 150-155, 1990.
10. Beebe, S.J., Redmon, J.B., Blackmore, P.F. and Corbin, J.D. Discriminative insulin antagonism of stimulatory effects of various cAMP analogs on adipocyte lipolysis and hepatocyte glycogenolysis. J. Biol. Chem. 260: 15781-15788, 1985.
11. Beltman, J., Sonnenburg, W.K. and Beavo, J.A. The role of protein phosphorylation in the regulation of cyclic nucleotide phosphodiesterases. Mol. Cell. Biochem. 127/128: 239-253, 1993.
12. Boyes, S. and Loten, E.G. Purification of an insulin-sensitive cyclic AMP phosphodiesterase from rat liver. Eur. J. Biochem. 174: 303-309, 1988.
13. Butcher, R.W. and Sutherland, E.W. Adenosine 3′-5′-monophosphate in biological materials. J. Biol. Chem. 237: 1244-1249, 1962.
14. Challis, R.A. and Nicholson, C.D. Effects of selective phosphodiesterase inhibition on cyclic AMP hydrolysis in rat cortical slices. Br. J. Pharmacol. 99: 47-52, 1990.
15. Charbonneau, H. Structure-function relationship among cyclic nucleotide phosphodiesterase. En: J.A. Beavo y M.D. Houslay (Eds.): Cyclic Nuclotide Phosphodiesrerases: Estructure, regulation and drug action. John Wiley and Sons, Chichester, R.U. 2: 267-296, 1990.
16. Charbonneau, H., Beier, N., Walsh, K.A. and Beavo, J.A. Identification of a conserved domain among cyclic nucleotide phosphodiesterases from diverse species. Proc. Natl. Acad. Sci. USA 83: 9308-9312, 1986.
17. Chen, C.N., Denome, S. and Davis, R.L. Molecular analysis of cDNA clones and de corresponding genomic coding sequences of the Drosophila dunce gene, the structural gene for cAMP phosphodiesterase. Proc. Natl. Acad. Sci. USA 83: 9313-9317, 1986.
18. Colucci, W.S., Wright, R.F. and Braunwald, E. New positive inotropic agents in the treatment of congestive heart failure. N. Engl. J. Med. 314: 290-299, 1986.
19. Connely, M.C., Ayala, A. and Kierszenbaum, F. Effects of α- and β-adrenergic agonists on Trypanosoma cruzi interaction with host cells. J. Parasitol. 74: 379-386, 1988.
20. Conti, M., Monaco, L., Geremia, R. and Stefanini, M. Effect of phosphodiesterase inhibitors on Sertoli cell refractoriness: reversal of the impaired androgen aromatization. Endocrinology 118: 901-908, 1986.
21. Conti, M., Nemoz, G., Sette, C. and Vicini, E. Recent progress in understanding the hormonal regulation of phosphodiesterases. Endocrine Rev. 16: 370-389, 1995.
22. Conti, M., Toscano, M.V., Petrelli, L., Geremia, R. and Stefanini, M. Regulation of follicle-stimulating hormone and dibutiryl adenosine 3′-5′-monophosphate of a phosphodiesterase isoenzime of the Sertoli cell. Endocrinology 110: 1189-1196, 1982.
23. Conti, M., Toscano, M.V., Petrelli, L., Geremia, R. and Stefanini, M. Involvement of phosphodiesterase in the refractoriness of Sertoli cell. Endocrinology 113: 1845-1853, 1983.
24. Coso, O.A., Diaz Anel, A., Martinetto, H., Muschietti, J.P., Kazanietz, M., Fraidenraich, D., Torres, H.N. and Flawia, M.M. Characterization of a G-protein form Trypanosoma cruzi epimastigote membranes. Biochem. J. 287: 443-446, 1992.
25. De Castro, S.L., Meirelles, M.N.L. and Oliveira, M.M. Trypanosoma cruzi: adrenergic modulation of cAMP role in proliferation and differentiation in vitro. Exp. Parasitol. 64: 368-375, 1987.
26. De Castro, S.L. and Oliveira, M.M. Radioligand binding characterization of β-adrenergic receptors in the protozoa Trypanosoma cruzi. Comp. Biochem. Physiol. C87: 5-8, 1987.
27. Degerman E., Belfrage P., Newman A.H., Rice K.C. and Manganiello, V.C. Purification of a putative hormone-sensitive AMPc phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity chromatography. J. Biol. Chem. 262(2): 5797-5807, 1987.
28. m cAMP phosphodiesterase from bovine adipose tissue. Second Messengers and Phosphoproteins 12: 171-182, 1988.
29. Degerman, E., Moos Jr., M., Rascón, A., Vasta, V., Meacci, E., Smith, C.J., Lindgren, S., Andersson, K.E., Belfrage, P. and Manganiello, V. Single-step affinity purification, partial structure and properties of human platelet cGMP-inhibited cAMP phosphodiesterase. Biochim. Biophys. Acta 1205: 189-198, 1994.
30. Dunlap. P.V. and Callahan, S.M. Characterization of a Periplamic 3′-5′-cyclic nucleotide phosphodiesterase gene, cpdP, from the marine simbiotic bacterium Vibrio fischeri. J. Bacteriol. 175: 4615-4624, 1993.
31. Gillespie, P.G. Phosphodiesterases in visual transduction by rods and cones. En: J. Beavo, y M.D. Houslay (Eds.): Cyclic Nucleotide Phosphodiesterases: Structure, Regulation and Drug Action, John Wiley & Sons, Chichester, 1990. pp. 161-184.
32. Gilman, A.G. G-Proteins: transducers of receptor-generated signals. Ann. Rev. Biochem. 56: 615-649, 1987.
33. Gonçalves, M.F., Zingales, B. and Colli, W. cAMP phosphodiesterase and activator protein of mammalian cAMP phosphodiesterase from Trypanosoma cruzi. Mol. Biochem. Parasitol. 1: 107-118, 1980.
34. Grant, P. and Colman, R.W. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase. Biochemistry 23: 1801-1807, 1984.
35. m cAMP phosphodiesterase markedly stimulates the catalytic activity. Proc. Natl. Acad. Sci. USA 85: 9071-9075, 1988.
36. m cAMP phosphodiesterase inhibition in tracheal relaxation and bronchodilation in the guinea pig. J. Pharmacol. Exp. Therap. 251: 199-206, 1989.
37. Harrison, S.A., Reifsnyder, D.H., Gallis, B., Cadd, G.S. and Beavo, J.A. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs. Mol. Pharmacol. 29: 506-514, 1986.
38. Heath, S., Hieny, S. and Sher, A. A cyclic AMP inducible gene expressed during the development of infective stages of Trypanosoma cruzi. Mol. Biochem. Parasitol. 43: 133-142, 1990.
39. Hidaka, H. and Asano, T. Human blood platelet 3′-5′ cyclic nucleotide phosphodiesterase. Biochim. Biophys. Acta 429: 485-497, 1976.
40. Hidaka, H. and Endo, T. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase-basic and potential clinical applications. Adv. Cyclic. Nucleotide Res. 16: 245-259, 1984.
41. Hoyer, L.L., Cieslinski, L.B., McLaughlin, M.M., Torphy, T.J., Shatzman, A.R. and Livi, G.P. A Candida albicans cyclic nucleotide phosphodiesterase: cloning and expression in Saccharomyces cerevisiae and biochemical characterization of the recombinant enzyme. Microbiology 140: 1533-1542, 1994.
42. Hurley, J.B. Signal transduction enzymes of vertebrate photoreceptors. J. Bioenerg. Biomembr. 24: 219-226, 1992.
43. Kariya, T., Willie, L.J. and Dage, R.C. Biochemical studies on the mechanism of cardiotonic activity of MDL 17,043. J. Cardiovasc. Pharmacol. 4: 509-514, 1982.
44. Kincaid, R.L., Stith-Coleman, I.E. and Vaughan, M. Proteolytic activation of calmodulin-dependent cyclic nucleotide phosphodiesterase. J. Biol. Chem. 260: 9009-9015, 1985.
45. Lacombe, M.L., Podgorski, G., Franke, J. and Kessin, R. Molecular cloning and developmental expression of the cyclic nucleotide phosphodiesterase gene of Dictyostelium discoideum. J. Biol. Chem. 261: 16811-16817, 1986.
46. Lindgren, S., Rascón, A., Andersson, K.E., Manganiello, V.C. and Degerman, E. Selective inhibition of cGMP-inhibited and cGMP-noninhibited cyclic nucleotide phosphodiesterases and relaxation of rat aorta. Biochem. Pharmacol. 42, 545-552, 1991.
47. Lönnroth, P. and Smith, U. The antilipolytic effect of insulin in human adipocytes requires activation of the phosphodiesterase. Biochem. Biophys. Res. Commun. 141: 1157-1161, 1986.
48. MacFarland, R.T., Zelus, B.D. and Beavo, J.A. High concentrations of cGMP-stimulated phosphodiesterase mediate ANP-induced decreases in cAMP and steroidogenesis in adrenal glomerulosa cells. J. Biol. Chem. 266: 136-142, 1991.
49. m cAMP phosphodiesterase: probable target for antithrombotic agents. Proc. Natl. Acad. Sci. USA 83: 6660-6663, 1986.
50. Mancini, P.E. y Patton, C.L. Cyclic 3′-5′-adenosine monophosphate levels during developmental cycle of Trypanosoma brucei brucei in the rat. Mol. Biochem. Parasitol. 3: 19-31, 1981.
51. Manganiello, V.C. Subcellular localization and biological function of specific cyclic nucleotide phosphodiesterases. J. Mol. Cel. Cardiol. 19: 1037-1040, 1987.
52. Manganiello, V.C. and Elks, M.L. Regulation of particulate cAMP phosphodiesterase activity in 3T3-L1 adipocytes: The role of particulate phosphodiesterase in the antilipolytic action of insulin. En: P. Belfrage, J. Donnér y P. Stralfors (Eds.): Mechanism of insulin action. Elsevier Sci. Publishers, Amsterdam, 1986. pp. 147-166.
53. Meacci, E., Taira, M., Moos, M., Jr., Smith, C.J., Movsesian, M.A., Degerman, E., Belfrage, P. and Manganiello, V.C. Molecular cloning and expression of human myocardial cGMP-phosphodiesterase. Proc. Natl. Acad. Sci. USA 89: 3721-3725, 1992.
54. Martin, B.R., Voorheis, H.P. and Kennedy, E.L. Adenylate cyclase in bloodstream forms of Trypanosoma brucei brucei. Biochem. J. 175: 207-212, 1978.
55. McLauglin, S.K., McKinnon, P.J. and Margolskee, R.F. Gustducin is a taste-cell-specific G protein closely related to the transducins. Nature 357: 563-569, 1992.
56. Meeker, R.B. and Hardin, T.K. Muscarinic cholinergic receptor-mediated activation of phosphodiesterase. Mol. Pharmacol. 23: 384-392, 1982.
57. Michaeli, T., Bloom, T.J., Martins, T., Loughney, K., Ferguson, K., Riggs, M., Rodgers, L., Beavo, J.A. and Wigler, M. Isolation and characterization of a previously undetected human cAMP phosphodiesterase by complementation of cAMP phosphodiesterase-deficient Saccharomyces cerevisiae. J. Biol. Chem. 268: 12925-12932, 1993.
58. Modabber, F. Chagas Disease. Leishmaniasis. En: Tropical Disease Research Progress 1991-1992. Genève, 1993.
59. Nicholson, C.D., Challis, R. and Shahid, M. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. Trends Pharmacol. 12: 19-27, 1991.
60. Nikawa, J., Sass, P. and Wigler, M. Cloning and characterization of the low-affinity cyclic AMP phosphodiesterase gene of Saccharomyces cerevisiae. Mol. Cell. Biol. 7: 3629-3636, 1987.
61. Oppert, B., Cunnick, J.M., Hurt, D. and Takemoto, D.U. Identification of the retinal cyclic GMP phosphodiesterase inhibitory gamma-subunit interaction sites on the catalytic alpha-subunit. J. Biol. Chem. 266: 16607-16613, 1991.
62. Pang. D.C. Cyclic AMP and Cyclic GMP phosphodiesterases: Target for Drug Development. Drug. Dev. Res. 12: 85-92, 1988.
63. Peachell, P., Undem, B., Schleimer, R.P., MacGlashan Jr., D.W., Lichtenstein, L.M., Cieslinski, L.B. and Torphy, T.J. Preliminary identification and role of phosphodiesterase isozymes in human basophils. J. Immun. 148: 2503-2510, 1992.
64. Rangel-Aldao, R., Tovar, G. and De Ruiz, M.L. The cAMP receptor protein of Trypanosoma cruzi. J. Biol. Chem. 258: 6976-6983, 1983.
65. Rangel-Aldao, R., Triana, F., Comach, G., Abate, T., Fernández, V. and McMahon-Pratt, D. Intracellular signaling transduction in the differentiation of Trypanosoma cruzi: role of cAMP. Arch. Biol. Med. Exp. 21: 403-408, 1988.
66. Rascón, A., Lindgren, S., Stavenow, L., Belfrage, P., Andersson, K.E., Manganiello, V.C. and Degerman, E. Purification and properties of the cGMP-inhibited cAMP phosphodiesterase from bovine aortic smooth muscle. Biochim. Biophys. Acta 1134: 149-156, 1992.
67. Rascón, A., Degerman, E., Taira, M., Meacci, E., Smith, C.J., Manganiello, V., Beifrage, P. and Tornqvist, H. Identification of the phosphorylation site in vitro for cAMP-dependent protein kinase on the rat adipocite cGMP-inhibited cAMP phosphodiesterase. J. Biol. Chem. 269(16): 11962-11966, 1994.
68. Sass, P., Field, J., Nikawa, J., Toda, T. and Wigler, M. Cloning and characterization of the high affinity cAMP phosphodiesterase of Saccharomyces cereviciae. Proc. Natl. Acad. Sci. USA 83: 9308-9307, 1986.
69. Strada, S.J. and Thompson, W.J. Cyclic nucleotide phosphodiesterases. Adv. Cycl. Nucl. Res. 16: 1-442. 1984.
70. Strickler, J.E. and Patton, C.L. Adenosine 3′-5′-monophosphate in reproducing and differentiated Trypanosomes. Science 190: 1110-1112, 1975.
71. Stroop, S.D., Charbonneau, H. and Beavo, J. Direct photolabeling of the cGMP-stimulated cyclic nucleotide phosphodiesterase. J. Biol. Chem. 264: 13718-13725, 1989.
72. Stryer, L. Visual excitation and recovery. J. Biol. Chem. 266: 10711-10714, 1991.
73. Sutherland, E.W. and Rall, T.W. Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles. J. Biol. Chem. 232: 1077, 1958.
74. Taira, M., Hockman, S., Calvo., U.C., Taira M., Beifrage, P. and Manganiello, V.C. Molecular cloning of the rat adipocyte hormone-sensitive cyclic GMP-inhibited cyclic nucleotide phosphodiesterase. J. Biol. Chem. 268: 18573-18579, 1993.
75. +2-dependent cyclic AMP phosphodiesterase activity in Trypanosoma cruzi. Mol. Biochem. Parasitol. 17: 143-153, 1985.
76. Thompson, W.J. and Appleman, M.M. Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochemistry 10: 311-316, 1971.
77. Thompson, W.J. and Appleman, M.M. Characterization of cyclic nucleotide phosphodiesterase of rat tissues. J. Biol. Chem. 246: 3145-3150, 1971a.
78. Thompson, W.J. Cyclic nucleotide phosphodiesterases: Pharmacology, biochemistry and function. Pharm. Ther. 51: 13-33, 1991.
79. Thompson, W.J., Pratt, M.L. and Strada, S.J. Biochemical properties of high-affinity cyclic AMP phosphodies terases. Adv. Cyclic Nucleotide Res. 16: 137-148, 1984.
80. Torphy, T.J., Zhou, H.L., Burman, M. and Huang, L.B.F. Role of cyclic nucleotide phosphodiesterase isozymes in intact canine trachealis. Mol. Pharmacol. 39: 376-384, 1991.
81. Tucker, M.M., Robinson, J.B. and Stellwagen, E. The effect of proteolysis on the calmodulin activation of cyclic nucleotide phosphodiesterase. J. Biol. Chem. 256: 9051, 1981.
82. Vaughan, M., Danelo, M.A., Manganiello, V.C. and Strewler, G.J. Regulation of cyclic nucleotide phosphodiesterase activity. Adv. Cycl. Nucl. Res. 14: 263-271, 1981.
83. Walter, R.D. 3′-5′ cyclic AMP phosphodiesterase from Trypanosoma gambiense. Hoppe-Seyler's Z. Physiol. Chem. 355: 1443-1450, 1974.
84. Walter, R.D. Adenosine 3′-5′-cyclic monophosphate-binding proteins from Trypanosoma gambiense. Hoppe-Seylers Z. Physiol. Chem. 359: 607-612, 1978.
85. Walter, R.D. and Opperdoes, F.R. Subcellular distribution of adenylate cyclase, cAMP phosphodiesterase, protein kinase and phosphoprotein phosphatase in Trypanosoma brucei. Mol. Biochem. Parasitol. 6: 287-295, 1982.
86. Walter, R.D. Regulation of cAMP metabolism in Leishmania promastigotes and amastigotes. En: D. Slutszky (Ed.): The biochemistry of parasites. Pergamon Press, Oxford. 1981. pp. 151-167.
87. Walter, R.D., Buse, E., Ebert, F. Effect of cAMP on transformation and proliferation of Leishmania cells. Tropenmed. Parasit. 29: 439-447, 1978.
88. Wang, J.H., Sharma, R.K. and Mooibroek, M.J. Calmodulin-stimulated cyclic nucleotide phosphodiesterases. En: J. Beavo, y M.D. Houslay (Eds.): Cyclic Nucleotide Phosphodiesterases: Structure, Regulation and Drug Action. John Wiley & Sons, Chichester, 1990. pp. 1959.
89. Weishaar, R.E., Burrows, S.D., Kobylarz, D.C., Quade, M.M. and Evans, D.B. Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac, smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents. Biochem. Pharmacol. 35: 787-800, 1986.
90. Weishaar, R.E., Cam, M.H. and Bristol, J.A. A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity. J. Med. Chem. 28: 537-545, 1985.
91. Yamamoto, T., Lieberman, F., Osborne, J.C., Jr., Manganiello, V.C., Vaughan, M. and Hidaka, H. Selective inhibition of two adenosine cyclic 3′-5′-phosphate phosphodiesterases partially purified from calf liver. Biochemistry 23: 670-675, 1984.
92. Van, C., Zhao, A.Z., Bentley, J.K. and Beavo., J.A. The calmodulin-dependent phosphodiesterase gene PDE1C encodes several functionally different splice variants in a tissue-specific manner. J. Biol. Chem. 271: 25699-25706, 1996.